These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24383128)

  • 1. The effect of adenovirus-conjugated NDRG2 on p53-mediated apoptosis of hepatocarcinoma cells through attenuation of nucleotide excision repair capacity.
    Cao W; Zhang JL; Feng DY; Liu XW; Li Y; Wang LF; Yao LB; Zhang H; Zhang J
    Biomaterials; 2014 Jan; 35(3):993-1003. PubMed ID: 24383128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Myc downstream-regulated gene 2 is involved in p53-mediated apoptosis.
    Liu N; Wang L; Li X; Yang Q; Liu X; Zhang J; Zhang J; Wu Y; Ji S; Zhang Y; Yang A; Han H; Yao L
    Nucleic Acids Res; 2008 Sep; 36(16):5335-49. PubMed ID: 18689861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of radiotherapy and adenovirus-mediated p53 gene therapy for MDM2-overexpressing hepatocellular carcinoma.
    Koom WS; Park SY; Kim W; Kim M; Kim JS; Kim H; Choi IK; Yun CO; Seong J
    J Radiat Res; 2012; 53(2):202-10. PubMed ID: 22510592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphiregulin impairs apoptosis-stimulating protein 2 of p53 overexpression-induced apoptosis in hepatoma cells.
    Liu K; Lin D; Ouyang Y; Pang L; Guo X; Wang S; Zang Y; Chen D
    Tumour Biol; 2017 Mar; 39(3):1010428317695026. PubMed ID: 28351301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASPP2 enhances chemotherapeutic sensitivity through the down-regulation of XIAP expression in a p53 independent manner in hepatocellular carcinoma.
    Yang T; Gao Y; Liu D; Wang Y; Wu J; Liu X; Shi Y; Chen D
    Biochem Biophys Res Commun; 2019 Jan; 508(3):769-774. PubMed ID: 30528232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic tumor suppression by adenovirus-mediated inhibitor of growth 4 and interleukin-24 gene cotransfer in hepatocarcinoma cells.
    Xie Y; Lv H; Sheng W; Miao J; Xiang J; Yang J
    Cancer Biother Radiopharm; 2011 Dec; 26(6):681-95. PubMed ID: 21988227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo.
    Liu X; Xu J; Wang S; Yu X; Kou B; Chai M; Zang Y; Chen D
    Int J Oncol; 2017 Oct; 51(4):1291-1299. PubMed ID: 28902369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus X protein inhibits nucleotide excision repair.
    Jia L; Wang XW; Harris CC
    Int J Cancer; 1999 Mar; 80(6):875-9. PubMed ID: 10074921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling.
    Lu WJ; Chua MS; So SK
    Oncotarget; 2015 Dec; 6(39):41722-35. PubMed ID: 26497681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased transcription-coupled nucleotide excision repair capacity is associated with increased p53- and MLH1-independent apoptosis in response to cisplatin.
    Stubbert LJ; Smith JM; McKay BC
    BMC Cancer; 2010 May; 10():207. PubMed ID: 20470425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NDRG2 overexpression suppresses hepatoma cells survival during metabolic stress through disturbing the activation of fatty acid oxidation.
    Pan T; Zhang M; Zhang F; Yan G; Ru Y; Wang Q; Zhang Y; Wei X; Xu X; Shen L; Zhang J; Wu K; Yao L; Li X
    Biochem Biophys Res Commun; 2017 Feb; 483(2):860-866. PubMed ID: 28069379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adenovirus-mediated killing of hepatocellular carcinoma HepG2 cells by heterogeneous fusion gene NT4p53(N15)Ant].
    Li YP; Qiu SD; Song LP; Wang QY; Yang GX
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):936-40. PubMed ID: 17666320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N‑Myc downstream‑regulated gene 2 suppresses the proliferation of T24 human bladder cancer cells via induction of oncosis.
    Huang J; Wu Z; Wang G; Cai Y; Cai M; Li Y
    Mol Med Rep; 2015 Oct; 12(4):5730-6. PubMed ID: 26239274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenoviral-mediated transfer of p53 gene enhances TRAIL-induced apoptosis in human hepatocellular carcinoma cells.
    Inoue H; Shiraki K; Murata K; Sugimoto K; Kawakita T; Yamaguchi Y; Saitou Y; Enokimura N; Yamamoto N; Yamanaka Y; Nakano T
    Int J Mol Med; 2004 Aug; 14(2):271-5. PubMed ID: 15254777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus siMDM2 and NDRG2 Gene Therapy Inhibits Cell Proliferation and Induces Apoptosis of Squamous Cell Carcinoma.
    Wang S; Chen N; Dong N; Lu L; Liu L; Zhang L
    Cell Biochem Biophys; 2015 Nov; 73(2):513-518. PubMed ID: 27352346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FXR controls the tumor suppressor NDRG2 and FXR agonists reduce liver tumor growth and metastasis in an orthotopic mouse xenograft model.
    Deuschle U; Schüler J; Schulz A; Schlüter T; Kinzel O; Abel U; Kremoser C
    PLoS One; 2012; 7(10):e43044. PubMed ID: 23056173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperthermia-induced NDRG2 upregulation inhibits the invasion of human hepatocellular carcinoma via suppressing ERK1/2 signaling pathway.
    Guo Y; Ma J; Wu L; Wang Q; Li X; Li X; Zhang Y; Zhang J; Yao L; Zhang J; Liu W
    PLoS One; 2013; 8(4):e61079. PubMed ID: 23630579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis.
    Teoh N; Pyakurel P; Dan YY; Swisshelm K; Hou J; Mitchell C; Fausto N; Gu Y; Farrell G
    Gastroenterology; 2010 Mar; 138(3):1155-65.e1-2. PubMed ID: 19919837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner.
    Zhu Z; Luo Z; Li Y; Ni C; Li H; Zhu M
    Hepatology; 2009 Feb; 49(2):504-12. PubMed ID: 19085961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WP1130 increases doxorubicin sensitivity in hepatocellular carcinoma cells through usp9x-dependent p53 degradation.
    Liu H; Chen W; Liang C; Chen BW; Zhi X; Zhang S; Zheng X; Bai X; Liang T
    Cancer Lett; 2015 Jun; 361(2):218-25. PubMed ID: 25749422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.